Page last updated: 2024-10-27

fluoxetine and Intraventricular Septal Defects

fluoxetine has been researched along with Intraventricular Septal Defects in 1 studies

Fluoxetine: The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.
fluoxetine : A racemate comprising equimolar amounts of (R)- and (S)-fluoxetine. A selective serotonin reuptake inhibitor (SSRI), it is used (generally as the hydrochloride salt) for the treatment of depression (and the depressive phase of bipolar disorder), bullimia nervosa, and obsessive-compulsive disorder.
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine : An aromatic ether consisting of 4-trifluoromethylphenol in which the hydrogen of the phenolic hydroxy group is replaced by a 3-(methylamino)-1-phenylpropyl group.

Research Excerpts

ExcerptRelevanceReference
"Fluoxetine was associated with an increased risk of isolated ventricular septal defects (adjusted OR 2."1.37Selective serotonin reuptake inhibitors and risk for major congenital anomalies. ( Artama, M; Gissler, M; Malm, H; Ritvanen, A, 2011)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Malm, H1
Artama, M1
Gissler, M1
Ritvanen, A1

Other Studies

1 other study available for fluoxetine and Intraventricular Septal Defects

ArticleYear
Selective serotonin reuptake inhibitors and risk for major congenital anomalies.
    Obstetrics and gynecology, 2011, Volume: 118, Issue:1

    Topics: Abnormalities, Drug-Induced; Adolescent; Adult; Alcohol Drinking; Female; Finland; Fluoxetine; Heart

2011